Patent · US Active

GLP-1R agonists and uses thereof

US10954221B2 · kind B2 · utility

7Cited by

1References

4Claims

0Family size

Assignee

QILU REGOR THERAPEUTICS INC. · CN

Inventors

Wenge Zhong · Thousand Oaks, US
Wei Guo · Shanghai, CN

Key dates

Filing date	Jun 16, 2020
Grant date	Mar 23, 2021
Priority date	—
Expiry date	Jun 16, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D471/04
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present disclosure provides compounds of Formula (I) and pharmaceutical compositions thereof, for use in, e.g. treating type 2 diabetes mellitus, pre-diabetes, obesity, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, and cardiovascular disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.